MORE►
Brian Tyler
McKesson CEO Brian Tyler [Photo: McKesson]
McKesson To Sell $1.25B Minority Stake in Medical-Surgical Unit to Apollo Ahead of Planned IPO
by Quincy Preston | Apr 21, 2026
The deal with Apollo Funds values Medical-Surgical Solutions at $13 billion. It’s a key step as McKesson prepares to spin off the unit and take it public in the second half of 2027.
by Lance Murray |
Feb 4, 2025
McKesson said it will acquire an 80% interest in the provider of general ophthalmology and retina management services. PRISM Vision physicians will continue to retain a 20% interest in their company.
MORE►
by Lance Murray |
Aug 26, 2024
Florida-based Core Ventures was established by the Florida Cancer Specialists & Research Institute, a physician-owned community oncology practice. With the multi-billion-dollar acquisition, CORE Ventures will join McKesson's US Oncology Network to advance "affordable cancer care and better patient outcomes."
MORE►
by Kevin Cummings |
Jun 23, 2022
Two giants in their industry are teaming up to accelerate cancer research. The new joint venture is an "important step forward" to increase access to clinical trials, says McKesson CEO Brian Tyler, McKesson CEO.
Separate from the joint venture deal, McKesson will acquire Genospace, a personalized precision medicine platform that’s part of HCA’s research institute.
MORE►
